Research Progress in Targeted Therapy of Hepatocellular Carcinoma | Zendy

Qiong Chen | Zendy; Xuefeng Yang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Research Progress in Targeted Therapy of Hepatocellular Carcinoma

Author(s) -

Qiong Chen,

Xuefeng Yang

Publication year - 2021

Publication title -

chinese medical sciences journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.215

H-Index - 21

ISSN - 1001-9294

DOI - 10.24920/003737

Subject(s) - medicine , hepatocellular carcinoma , targeted therapy , oncology , cancer research , toxicity , cancer

Hepatocellular carcinoma (HCC) is one of the most common malignancies, and its treatment is limited. With the understanding of key genes and signaling pathways in the occurrence and development of HCC, targeted drugs with high selectivity and low toxicity have been developed continuously, bringing a variety of options for the treatment of advanced HCC. In this article, the research progress on representative drugs of targeted therapy and potential therapeutic targets for HCC are reviewed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research